Garcia-Lázaro Santiago, Madrid-Costa David, Ferrer-Blasco Teresa, Montés-Micó Robert, Cerviño Alejandro
Optometry Research Group (GIO), Department of Optics, University of Valencia, Valencia, Spain.
Optom Vis Sci. 2012 Jan;89(1):E62-9. doi: 10.1097/OPX.0b013e318237a9d2.
To apply a commercially available high-resolution spectral domain optical coherence tomographer (SOCT) to assess the change in tear volume after application of a new artificial tears formulation specifically developed for contact lens (CL) users.
Twenty OD from young healthy CL wearers (mean age, 24.7 ± 3.5 years) with refractive errors ranging from -0.75 to -2.50 D (mean, -1.56 ± 0.69 D) were examined. All subjects were fitted with Focus Dailies CL (Ciba Vision), and two drops of Blink Contacts (AMO), lubricating formulation specifically developed for CL wearers, were instilled after baseline measures. Tear meniscus volume (TMV) was measured immediately after and 1 min, 10, 30, and 60 min after instillation using the Copernicus HR SOCT (Optopol Tech., SA, Poland). TMV was calculated from the local area from tomograms assuming a regular distribution of the tear meniscus across the eyelid. Three scans were taken at each of the time points.
Mean meniscus volume without CL was 1.35 ± 1.18 μL, volume with CL was higher, 1.71 ± 1.56 μL but not significantly different (mean difference, 0.36 ± 1.31 μL). After instillation of Blink Contacts eye drops, meniscus volume increased to an average of 4.10 ± 2.91 μL. Repeated measures analysis of variance showed that values after 10 min were significantly higher than before instillation of eye drops (p < 0.01; mean difference, 0.77 ± 0.65 μL). After 30 and 60 minutes, values of TMV decreased to almost baseline (average mean difference from baseline 0.19 ± 0.18 μL at t30, p < 0.001, and 0.06 ± 0.08 μL at t60, p = 0.004).
High-resolution imaging of the lower tear film meniscus with SOCT systems provides useful measures of tear volume. An artificial tear formulation provides a change in tear volume that is maintained beyond 10 min, although further study, using control groups, would be desirable to determine the consistency of those higher-than-baseline values observed over time.
应用市售高分辨率光谱域光学相干断层扫描仪(SOCT),评估一种专门为隐形眼镜(CL)使用者研发的新型人工泪液制剂应用后泪液体积的变化。
对20名年轻健康的CL佩戴者(平均年龄24.7±3.5岁)的右眼进行检查,其屈光不正范围为-0.75至-2.50 D(平均-1.56±0.69 D)。所有受试者均佩戴Focus Dailies CL(博士伦),在进行基线测量后,滴入两滴Blink Contacts(眼力健),这是一种专门为CL佩戴者研发的润滑制剂。使用哥白尼HR SOCT(波兰Optopol Tech., SA公司)在滴入后即刻、1分钟、10分钟、30分钟和60分钟测量泪河体积(TMV)。根据断层扫描的局部区域计算TMV,假设泪河在眼睑上呈规则分布。每个时间点进行三次扫描。
不佩戴CL时的平均泪河体积为1.35±1.18μL,佩戴CL时体积更高,为1.71±1.56μL,但差异无统计学意义(平均差异0.36±1.31μL)。滴入Blink Contacts眼药水后,泪河体积平均增加至4.10±2.91μL。重复测量方差分析显示,10分钟后的数值显著高于滴入眼药水前(p<0.01;平均差异0.77±0.65μL)。30分钟和60分钟后,TMV值降至几乎基线水平(t30时与基线的平均差异为0.19±0.18μL,p<0.001;t60时为0.06±0.08μL,p=0.004)。
使用SOCT系统对下泪膜泪河进行高分辨率成像可提供有用的泪液体积测量方法。一种人工泪液制剂可使泪液体积发生变化,且这种变化可持续超过10分钟,不过使用对照组进行进一步研究以确定随时间观察到的高于基线值的一致性是可取的。